Microsofts Anthropic Partnership Could Deliver 43 Billion Azure Revenue by 2030 HSBC Estimates Michael Jacksons Off the Wall Album Reaches New Billboard Peaks Signaling Catalog Value Growth Micron UnitedHealth Rocket Lab Highlight Divergent Market Trends Barrons Reports Oppenheimer Suggests Golub Capitals Fair Value May Align Closely with Book Value STT Hike and Easing Volatility Weigh on Index Options Volumes US Pauses Arms Sales to Taiwan Amid Iran Conflict Acting Navy Chief Indicates Accendra Health Inc ACH Q1 2026 Earnings EPS Beats Estimates by 609 as Loss Narrows to 004 Per Share TScan Therapeutics Q1 2026 Earnings Narrowing Loss Despite EPS Miss Stock Gains on Pipeline Progress PKX Q4 2025 Earnings Massive EPS Miss Exceeds Negative Surprise Amidst Challenging Conditions STC Q1 2026 Earnings EPS Surges Past Estimates by 485 SAIC Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency KNTK Q1 2026 Earnings Significant EPS Miss as Company Posts Surprise Loss New Era Energy Digital Inc Warrants NUAIW Slip 5 Testing Key Support as Momentum Wanes Twist Bioscience TWST Holds Steady Near Midpoint as Key Levels Define Trading Range Selective Insurance Group Preferred Stock SIGIP Holds Near Support Amid Slight Decline Rentokil Initial RTO Moves Modestly Higher Holding Above Key Support Enovix Corporation ENVX Surges on Renewed Buying Interest Key Levels in Focus GDRX Q1 2026 Earnings EPS Misses Estimates Slightly as Stock Gains Despite Headwinds SCVL Q1 2026 Earnings EPS Slightly Misses Estimates Stock Jumps on Resilient Demand WING Q1 2026 Earnings EPS Surges Past Expectations Shares Rally 585 Adamas Trust Inc ADAM Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Movement ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Controlled Spending Amid Clinical Progress ONTO Q1 2026 Earnings EPS Misses Estimates by 163 Amid Unreported Revenue Trump Signals No Rush on Iran Nuclear Deal Naval Blockade to Continue Deere Q1 2026 Earnings Strong EPS Beat Amidst Weak Agricultural Demand Sionna Therapeutics SION Edges Higher as Biotech Sentiment Improves Testing Key Resistance